Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

"The ability to trigger a robust, long-lasting immune response is a requisite feature for any cancer vaccine." Prostate ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Compare those grim statistics with the overall five-year survival rates for breast and prostate cancers (91 ... whom will be infused with the anti-cancer vaccine while the other half will receive ...

The new vaccine is "personalized," meaning it is ... At-home urine test screens for prostate cancer A simple at-home urine test is highly accurate at screening for prostate cancer, according ...

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later. The hope is that the vaccine primes the immune system to seek out and ...